Author(s): Zeinab Abdi, Mohammad-Ali Roozegar, Sepideh Beigi, Ali Khorshidi, Mohammad Azizian, Zahra Beigi

Email(s): havasian1991@gmail.com , mpvmpv559@gmail.com

DOI: 10.5958/0974-360X.2020.00163.8   

Address: Zeinab Abdi1, Mohammad-Ali Roozegar2, Sepideh Beigi3*, Ali Khorshidi4, Mohammad Azizian5, Zahra Beigi6
1Assistant Professor of Periodontology, School of Dentistry, Ilam University of Medical Sciences, Ilam, Iran
2Associate Professor of Periodontology, School of Dentistry, Ilam University of Medical Sciences, Ilam, Iran
3Student of Dentistry, School of Dentistry, Ilam University of Medical Sciences, Ilam, Iran
4Assistant Professor of Epidemiology, School of Medicine, Psychosocial Injuries Research Center, Ilam University of Medical Sciences, Ilam, Iran
5Assistant Professor of Prosthodontics, School of Dentistry, Ilam University of Medical Sciences, Ilam, Iran
6MD, School of Medicine, Ilam University of Medical Sciences, Ilam, Iran
*Corresponding Author

Published In:   Volume - 13,      Issue - 2,     Year - 2020


ABSTRACT:
Periodontitis is a destructive disease that targets tooth supporting structures. Simvastatin (SMV) are inhibitors of HMG-COA reductase enzyme that have complex interaction with cholesterol metabolites, inflammatory mediators, hormones and bone metabolism, thus having direct and important effects on extent and severity of periodontitis. The present study aims to evaluate the in vivo effect of mouthwash of CHX and SMV (.6 and 1.2 and 1.8%) as a local drug-delivery agent on clinical parameters in chronic periodontitis. 50 patients were selected and categorized into five treatment groups. At initial appointment SRP were done and clinical parameters were measured and mouthwashes of SMV (0.6 - 1.2 - 1.8) and CHX and placebo distributed among groups. Measurement of clinical parameters after one month repeated for all groups and required data was collected and analyzed. SRP with SMV (0.6 – 1.2 – 1.8) significantly improve the clinical parameters (AL-BOP-PD). Mouthwash of SMV 1.2 and 1.8 and CHX in decrease of BOP and PD and AL has no significant differences (P>0.05). Mouthwash of SMV 1.2 and 1.8 and CHX has significantly differences in decrease of BOP and PD than SMV .06 and placebo (P<.05). SMV (0.6 – 1.2 – 1.8) and CHX has significantly differences in decease of AL than Normal saline. With due attention to inhibition of inflammatory cytokines with SMV on periodontitis, SMV can be good alternative for CHX in chronic periodontitis patients.


Cite this article:
Zeinab Abdi, Mohammad-Ali Roozegar, Sepideh Beigi, Ali Khorshidi, Mohammad Azizian, Zahra Beigi. Using Simvastatin Mouthwash (0.6%, 1.2% and 1.8%) on the Improvement of Clinical Parameters in Patients with Chronic Periodontitis. Research J. Pharm. and Tech 2020; 13(2):862-866. doi: 10.5958/0974-360X.2020.00163.8

Cite(Electronic):
Zeinab Abdi, Mohammad-Ali Roozegar, Sepideh Beigi, Ali Khorshidi, Mohammad Azizian, Zahra Beigi. Using Simvastatin Mouthwash (0.6%, 1.2% and 1.8%) on the Improvement of Clinical Parameters in Patients with Chronic Periodontitis. Research J. Pharm. and Tech 2020; 13(2):862-866. doi: 10.5958/0974-360X.2020.00163.8   Available on: https://rjptonline.org/AbstractView.aspx?PID=2020-13-2-67


Recomonded Articles:

Author(s): Zeinab Abdi, Mohammad-Ali Roozegar, Sepideh Beigi, Ali Khorshidi, Mohammad Azizian, Zahra Beigi

DOI: 10.5958/0974-360X.2020.00163.8         Access: Open Access Read More

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags